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Diagnosing Alzheimer's disease through MRI neuroimaging biomarkers has been used as a 
complementary marker for traditional clinical markers to improve diagnostic accuracy and 
also help in developing new pharmacotherapeutic trials. It has been revealed that longitudinal 
analysis of the whole brain atrophy has the power of discriminating Alzheimer's disease and 
elderly normal controls. In this work, effect of involving intermediate atrophy rates and 
impact of using uncorrelated principal components of these features instead of original ones 
on discriminating normal controls and Alzheimer's disease subjects, is inspected. In fact, 
linear discriminative analysis of atrophy rates is used to classify subjects into Alzheimer's 
disease and controls. Leave-one-out cross-validation has been adopted to evaluate the 
generalization rate of the classifier along with its memorization. Results show that 
incorporating uncorrelated version of intermediate features leads to the same memorization 
performance as the original ones but higher generalization rate. As a conclusion, it is revealed 
that in a longitudinal study, using intermediate MRI scans and transferring them to an 
uncorrelated feature space can improve diagnostic accuracy. 
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